Daniel Morgan has over 20 years’ experience of private capital markets, including venture investment in life sciences. He is a Member of the Institute of Chartered Accountants in England and Wales.
Daniel Morgan
Latest news
-
LifeArc announces partnership with Elpida Therapeutics to accelerate gene therapies for ultra-rare diseases in children
-
LifeArc Translational Science Summit 2026: Charting new paths for rare disease
-
From curiosity to career: LifeArc placement students share their stories for British Science Week